BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34519129)

  • 1. Exosome-mediated lncRNA SNHG11 regulates angiogenesis in pancreatic carcinoma through miR-324-3p/VEGFA axis.
    Fang X; Cai Y; Xu Y; Zhang H
    Cell Biol Int; 2022 Jan; 46(1):106-117. PubMed ID: 34519129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis.
    Song W; Shi C
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p.
    Jin Y; Cao J; Hu X; Cheng H
    J Clin Lab Anal; 2021 Dec; 35(12):e24106. PubMed ID: 34762771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z; Guo N; Zhang XJ
    Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
    Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine improves oxygen-glucose deprivation/reoxygenation (OGD/R) -induced neurological injury through regulating SNHG11/miR-324-3p/VEGFA axis.
    Chen Y; Fan Z; Wu Q
    Bioengineered; 2021 Dec; 12(1):4794-4804. PubMed ID: 34334080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway.
    Li W; Han S; Hu P; Chen D; Zeng Z; Hu Y; Xu F; Tang J; Wang F; Zhao Y; Huang M; Zhao G
    Cell Death Dis; 2021 Sep; 12(9):830. PubMed ID: 34480024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.
    Shang D; Xie C; Hu J; Tan J; Yuan Y; Liu Z; Yang Z
    J Cell Mol Med; 2020 Jan; 24(1):588-604. PubMed ID: 31724333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
    Yin Z; Zhou Y; Ma T; Chen S; Shi N; Zou Y; Hou B; Zhang C
    J Cell Mol Med; 2020 May; 24(9):5028-5038. PubMed ID: 32301277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.
    Cao W; Zeng Z; He Z; Lei S
    Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
    Xu J; Xu W; Yang X; Liu Z; Sun Q
    Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal lncRNA PVT1/VEGFA Axis Promotes Colon Cancer Metastasis and Stemness by Downregulation of Tumor Suppressor miR-152-3p.
    Lai SW; Chen MY; Bamodu OA; Hsieh MS; Huang TY; Yeh CT; Lee WH; Cherng YG
    Oxid Med Cell Longev; 2021; 2021():9959807. PubMed ID: 34336125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
    Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
    Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p/VEGFA.
    Liu S; Gao J; Chen J
    Microvasc Res; 2021 Nov; 138():104233. PubMed ID: 34411571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma.
    Shi C; Yang Q; Pan S; Lin X; Xu G; Luo Y; Zheng B; Xie X; Yu M
    Cancer Biol Ther; 2020 Jul; 21(7):604-614. PubMed ID: 32329664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.